Arbele Pty Ltd
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients (NCT05411133) | Arbele Pty Ltd | 2022-05-30 |
Track Arbele Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.